Journal of Medicinal Chemistry · 2013 · 25 citations · 37 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular OncologyAdhesion MoleculesAllosteric Drug DesignCell Adhesion ReceptorsDrug-receptor InteractionsLigand BindingReceptor-ligand InteractionsAllosteric Site CharacterizationBiological Activity FeaturesCell Adhesion LigandsIntegrin AntagonistsIntercellular Adhesion Molecule 1Leukocyte FunctionMurine ModelsStructure-based Allosteric Design
The integrin leukocyte function associated antigen 1 (LFA-1) binds the intercellular adhesion molecule 1 (ICAM-1) by its α(L)-chain inserted domain (I-domain). This interaction plays a key role in cancer and other diseases. We report the structure-based design, small-scale synthesis, and biological activity evaluation of a novel family of LFA-1 antagonists. The design led to the synthesis of a family of highly substituted homochiral pyrrolidines with antiproliferative and antimetastatic activity in a murine model of colon carcinoma, as well as potent antiadhesive properties in several cancer cell lines in the low micromolar range. NMR analysis of their binding to the isolated I-domain shows that they bind to the I-domain allosteric site (IDAS), the binding site of other allosteric LFA-1 inhibitors. These results provide evidence of the potential therapeutic value of a new set of LFA-1 inhibitors, whose further development is facilitated by a synthetic strategy that is versatile and fully stereocontrolled.
37
Chemokines Trigger Immediate β2 Integrin Affinity and Mobility Changes
Gabriela Constantin, Cinzia Giagulli, Laura Piccio et al. · Immunity · 2000 · 517 citations · Full text